α-Pinene Inhibits Human Prostate Cancer Growth in a Mouse Xenograft Model

Yunqi Zhao1, Ran Chen, Yun Wang

  • 1School of Pharmaceutical Sciences and Yunnan Provincial Key Laboratory of Pharmacology for Natural Products, Kunming Medical University, Kunming, PR China.

Chemotherapy
|October 26, 2017
PubMed
Abstract

Insights

Alpha-pinene, a natural terpenoid, effectively inhibits prostate cancer cell growth and progression. This study demonstrates its potential as a therapeutic agent for prostate cancer treatment.

Area of Science:

  • Natural product chemistry
  • Cancer biology
  • Pharmacology

Background:

  • Alpha-pinene is a prevalent natural terpenoid with documented cancer-preventive properties.
  • Prostate cancer remains a significant global health concern, necessitating novel therapeutic strategies.

Purpose of the Study:

  • To investigate the efficacy of alpha-pinene in inhibiting prostate cancer growth.
  • To explore the mechanisms underlying alpha-pinene's anti-cancer effects in vitro and in vivo.

Main Methods:

  • Cytotoxicity assessed via MTT assay.
  • Apoptosis and cell cycle analysis performed using flow cytometry.
  • Subcutaneous xenograft tumors established in nude mice using the PC-3 cell line.

Main Results:

  • Alpha-pinene significantly suppressed human prostate cancer cell proliferation and induced apoptosis and cell cycle arrest in vitro.
  • In vivo, alpha-pinene treatment markedly inhibited tumor progression in xenograft models.
  • Reduced expression of proliferation markers (Ki67, PCNA) and increased apoptosis (TUNEL assay) observed in treated tumors.

Conclusions:

  • Alpha-pinene demonstrates significant anti-prostate cancer activity in a preclinical xenograft model.
  • These findings suggest alpha-pinene holds promise as a potential therapeutic agent for prostate cancer.